During wound healing, cell migration, proliferation, differentiation, and enhanced biosynthetic activities are observed at the sites of injury. Interactions between extracellular matrix (ECM) components and specific cell surface receptors, such as integrins, initiate cascades of signal transduction leading to various cellular responses. This review will focus on the biological functions of several ECM components, such as osteopontin (OPN), tenascin (TCN), and lumican (Lum). The loss of OPN or TCN reduces macrophage invasion and myofibroblast differentiation in the healing stroma and is associated with the suppression of fibrogenic gene expression in response to injury sustained in mice. Gene expression analysis showed that the lack of OPN or TCN resulted in the inhibition of proinflammatory and fibrogenic gene expression. It has been shown that Lum also modulates cell adhesion, migration, and proliferation, thus contributing to corneal epithelial wound healing. Interestingly, OPN-, TCN-, or Lum-null mice had reduced Smad activity and epithelial-mesenchymal transitions. Smads are nuclear effectors of transforming growth factor-b and regulate transcription. However, it is still not clear as to how individual ECM components initiate the signaling pathway. We hypothesized that a cell surface receptor for these ECM components may mediate the matrikine functions of Lum. To identify the specific receptor for Lum, we developed purified recombinant glutathione S-transferase-Lum. Using this, we identified a potential receptor for Lum that modulated wound healing.
T he cornea is a specialized avascular and transparent tissue that requires a highly organized extracellular matrix (ECM) to refract light and maintain its function. After an injury is sustained, the activation of keratocytes (corneal fibroblasts) and the generation of myofibroblasts lead to neovascularization, scarring, and corneal opacification. 1 Although growth factors and cytokines are involved in this process, many ECM components play an important role at the site of scars and neovascularization in the cornea, as with scarring in other internal organs (liver and pancreas). 1 It is well known that cell-ECM interactions modulate many key actions in wound healing, including cell differentiation, proliferation, migration, and apoptosis ( Fig. 1) . Thus, ECM components that can regulate cell activity positively or negatively are known as matrikines. Various ECM components are newly expressed during tissue repair in a transforming growth factor (TGF)-b-dependent mechanism. 2 For example, fibronectin that is newly expressed by activated keratocytes accumulates in the healing stroma and promotes epithelial adhesion and migration. Osteopontin (OPN) and tenascin-C (TNC), which are ligands of a9 integrin, are also expressed in fibroblasts and myofibroblasts in injured corneal tissues. The specific roles of these 2 matrix components in the corneal wound healing process are yet to be clearly identified. First, we focused on the roles of these 2 proteins during corneal wound healing, because growth factor signaling is reportedly modulated by ECM-integrin interactions. Overall, our work suggests that a9-binding ligands such as OPN and TNC modulate TGF-b-dependent gene expression during the process of primary stromal repair in the mouse cornea. We suggest a potential receptor that binds to lumican (Lum) to induce matrikine modulation of wound healing.
INVOLVEMENT OF MATRIKINE IN CORNEAL WOUND HEALING
OPN is a matrix structural glycophosphoprotein that is also abundantly expressed in tissues during inflammation and repair. It functions as a cytokine that regulates the activity of macrophages, other immune cells, and resident tissue cells, such as epithelial cell types and mesenchymal cells, at the sites of injury. 3 It has been reported that the loss of OPN results in dilated airspace, rather than in alveolar obstruction (fibrosis), with a reduction of type I collagen deposition after the intratracheal administration of bleomycin sulfate. 4 Other examples of impaired wound healing in the absence of OPN have been observed in the heart, skin, and other tissues in mice. 5, 6 These phenomena might be caused, at least in part, by defective matrix deposition and reconstruction. Cell culture studies first showed that OPN is involved in cell adhesion and migration. 7 However, experimental liver fibrosis was reportedly more prominent in OPN-null mice as compared with that in wild-type mice, suggesting that the role of OPN in profibrogenic tissue reaction may be organ and tissue specific. 8 The roles of OPN in healing responses of injured corneal stroma have been investigated using OPN-deficient mice. The lack of OPN delayed the closure of an incision injury in mouse corneal stroma. 9 Gene expression analyses showed that the loss of OPN suppressed the injury-induced upregulation of a-smooth muscle actin and fibrogenic gene expression. A cell culture study further showed that OPN-null ocular fibroblasts (derived from the eye shell of newborn mice) had less fibrogenic gene expression than did wild-type cells. 10 TGF-b has the ability to regulate cell functions, including the proliferation, differentiation, migration, epithelialmesenchymal transition, and production of ECM, which play an important role during wound healing. TGF-b propagates the signal through a signal transduction network involving the type I and type II cell surface receptors and Smads. Persistent TGF-b function affects tissue fibrosis. 11, 12 Smads play a central role in the transduction of TGF-b receptor signals. The type I receptor phosphorylates receptor Smads (R-Smads), Smad2, and Smad3. Activated R-Smads oligomerize with CoSmad and Smad4. R-Smads/CoSmad shuttle to the nucleus to regulate gene transcription. 13 Interestingly, the lack of OPN blocked the activation of Smad3 and p38 in response to TGF-b1 exposure in cultured ocular fibroblasts. 14 Involvement of Smad3 in tissue fibrosis in vivo was demonstrated using Smad3-null mice. 15 p38 also participates in fibrogenic gene expression by affecting Smad linker signals and by other mechanisms. Therefore, the reduced activation of Smad3 and p38 might cause reduced fibrogenic responses in corneal stroma in vivo. Smad2 phosphorylation was not affected by the loss of OPN, perhaps explaining the expression of a-smooth muscle actin in cell cultures in response to TGF-b1. TNC, like fibronectin, is a wound healing-related matrix macromolecule that is temporarily upregulated in injured tissues. 16 It is a disulfidebonded hexamer composed of subunits with molecular weights in the range of 120 to 300 kDa. TNC is also abundantly detected at the invasive margin of cancers, suggesting its role in the progression and acquisition of invasive characteristics of cancer cells. Our studies have shown that the loss of TNC in C57BL/6-mice has an effect on corneal stromal wound healing similar to that of OPN deficiency, and leads to the impaired primary repair of incision wounds of the corneal stroma. 17 The loss of TNC also attenuates profibrogenic gene expression. 17 However, impaired stromal repair was not observed in TNC-knockout mice generated in other genetic backgrounds, even though the suppression of fibronectin was similarly observed. 18 In our studies, western blot analysis showed that the loss of TNC did not affect Smad3 phosphorylation, which is different from the effects seen on this signaling pathway in OPN-knockout mice (unpublished data). In lung fibroblasts, the loss of TNC reportedly reduced the total level of Smad3, leading to the attenuation of signaling. 19 We did not observe such findings in cultured ocular fibroblasts (unpublished data). Lum regulates collagenous matrix assembly in the cornea and is present as a glycoprotein in the connective tissues of other organs and in embryonic corneal stroma. In normal unwounded cornea, Lum is expressed by stromal keratocytes. Our previous studies showed that injured mouse corneal epithelium ectopically and transiently express Lum during the early phases of wound healing. 20 This suggests a potential Lum function that is unrelated to the regulation of collagen fibrillogenesis, for example, the modulation of epithelial cell adhesion or migration. Healing of corneal epithelial injury in Lum-null mice was significantly delayed compared with that in control mice. 20 These functions are likely mediated through the interactions of a leucine-rich repeat domain with other proteins in the extracellular space and/or plasma membrane proteins (our unpublished data from molecular docking analysis). For example, Chakravarti et al have suggested that Lum may interact with Toll-like receptor 4 to mediate its functions in inflammation. 21 However, the molecular and cellular mechanisms of interactions between Lum and proteins remain poorly understood. Lum is a matrikine that promotes corneal epithelium wound healing, modulates epithelium-mesenchyme transition during the healing of injured lens, and regulates the gene expression profiles of stromal keratocytes. 22, 23 Thus, it has been hypothesized that there is a cell surface receptor specific for Lum that mediates its matrikine functions. The nature of such a receptor remained unknown until our recent studies, which demonstrated that ALK5 is a potential Lum receptor (our unpublished data).
CONCLUSIONS
Endogenous OPN and TNC modulate the expression of fibrogenic or angiogenic cytokines and are involved in primary corneal tissue repair. OPN attenuates TGF-b-related Smad2 and p38 signals, but TNC does not. However, the levels of cross talk between TGF-b and a9 integrin signaling (at the receptor or cytoplasmic signal level) require further investigation. Lum functions as a matrikine and modulates corneal wound healing through a cell surface receptor identified as ALK5. This suggests that matrikines mediate their biological functions by inducing a signaling cascade after binding to specific cell surface receptors occurs (Fig. 2) .
